| 08-Jan-2024 | S | Outcome for Outcome Of The Board Meeting
Sub-division (stock split) of every 1(one) equity share of face value Rs. 5/- each into 5 (five) equity share of face value of Re.1/-
Company has approved Record date for Stock Split (Sub-division) of equity share of Rs.5/- per equity share to Re.1/- per equity share through Postal Ballot.
(As per BSE Announcement Dated on 12/02/2024)
Trading Members of the Exchange are hereby informed that REMEDIUM LIFECARE LTD, has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME
&
CODE
REMEDIUM LIFECARE LTD
(539561)
RECORD DATE
23/02/2024
PURPOSE
Subdivision of existing Equity Shares from One Equity Share of Rs.5/- each into Five Equity Shares of Re.1 /- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE
W.E.F.
23/02/2024
DR-724/2023-2024
Note: -
i. ISIN No. INE549S01028 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 23/02/2024.
ii. The new ISIN Number for Re. 1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 13.02.2024)
Company has approved Record date for Stock Split (Sub-division) of equity share of Rs.5/- per equity share to Re.1/- per equity share through Postal Ballot.
(As Per BSE Announcement Dated on 12/02/2024)
With reference to the captioned subject, we would like to inform you that Company has received NEW ISIN from CDSL and NSDL pursuant to sub division/ stock split of Face Value of the Equity Shares from Rs.5/- each to Re.1/- each. Please note New ISIN- INE54S01036.
With reference to the captioned subject, we would like to inform you that Remedium Lifecare Limited has received NEW ISIN from CDSL and NSDL pursuant to Subdivision / Stock Split of Face Value of the Equity shares from Rs. 5/- each to Re.1- each. Please note that the New ISIN of the Company is INE549S01036 and Sub division/ Stock Split of Equity Shares will take effect under New ISIN.
(As Per BSE Announcement Dated on 19/02/2024)
In Continuation of Notice No. 20240213-7 dated February 13,2024, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: -
Company Name & Scrip Code
REMEDIUM LIFECARE LTD
(539561)
New ISIN No.
INE549S01036
Remarks
Sub-division of Equity Shares from Rs.5/- to Re.1/-
The new ISIN number given above, for Equity Shares of Re.1/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 23-02-2024 (DR- 724/2023-2024)
(As Per BSE Notice Dated on 21.02.2024) | 23-Feb-2024 | |
| 23-Jun-2023 | S | Remedium Lifecare Ltd has informed BSE that the Board of Directors of the Company at their meeting held on 23/06/2023 ,inter alia, had considered and approved the:
1. Sub-division of Shares/ Stock Split of the Company.
Subject to the approval of the members in the Annual General Meeting and appropriate authorities, the Board has considered, approved and recommended for Sub-division of Company's 1 (One) Equity Share of Face Value of Rs. 10/- each into 2 (Two) Equity Shares of Face Value of Rs. 5/- each held as on the Record date which shall be decided for this purpose.
The Company has fixed Friday, September 01, 2023 as the Record Date for the purpose of ascertaining the names of the Shareholders who would be entitled to receive 2(Two) Equity Shares of the Face Value of Rs. 5/-each for every 1 (One) Equity Share of Face Value of Rs.10/- each held by them.
(As Per BSE Announcement Dated on 08/08/2023)
Trading Members of the Exchange are hereby informed that REMEDIUM LIFECARE LTD, has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
REMEDIUM LIFECARE LTD
(539561)
RECORD DATE
01.09.2023
PURPOSE
Subdivision of existing Equity Shares from One Equity Share of Rs.10/- each into Two Equity Shares of Rs 5/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.5/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
01/09/2023 DR-605/2023-2024
Note: -
i. ISIN No. INE549S01010 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 01/09/2023.
ii. The new ISIN Number for Rs. 5/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 09.08.2023)
In Continuation of Notice No. 20230809-44 dated August 09, 2023, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: -
Company Name & Scrip Code
REMEDIUM LIFECARE LTD
(539561)
New ISIN No.
INE549S01028
Remarks
Sub-division of equity shares from Rs.10/- to Rs.5/-
The new ISIN number given above, for Equity Shares of Rs.5/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 01-09-2023 (DR-605/2023-2024)
(As Per BSE Notice Dated on 23.08.2023) | 01-Sep-2023 | |
| 26-Jun-2024 | B | Trading Members of the Exchange are hereby informed that, REMEDIUM LIFECARE LTD has fixed Record Date for the purpose of Bonus Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
REMEDIUM LIFECARE LTD
(539561)
RECORD DATE
06.07.2024
PURPOSE
Issue of 03 (Three) Bonus Equity Shares of Re.1/- each for every 01 (One) existing Equity Share of Re.1/- each held.
Ex-Bonus basis from Date & Sett. No.
05/07/2024 DR- 667/2024-2025 | 06-Jul-2024 | 3:1 |
| 23-Jun-2023 | B | 9:5 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, REMEDIUM LIFECARE LIMITED has fixed Record Date for the purpose of Bonus Issue. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
REMEDIUM LIFECARE LIMITED
(539561)
RECORD DATE
29.07.2023
PURPOSE
Issue of 9 (Nine) Bonus Equity Shares of Rs.10/- each for every 5 (Five) existing Equity Shares of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
28/07/2023 DR-581/2023-2024
(As Per BSE Notice Dated on 19.07.2023) | 29-Jul-2023 | 9:5 |
| 09-Nov-2024 | BC | Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Remedium Lifecare Ltd has informed BSE th | 14-Nov-2024 | |
| 31-Oct-2024 | BC | In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their | 31-Oct-2024 | |
| 31-Oct-2024 | BC | In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their | 31-Oct-2024 | |
| 27-Aug-2024 | BC | Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2024 inter alia to consider and approve 1. Acquisition of a company Airowater Glo | 04-Sep-2024 | |
| 20-Jul-2024 | BC | M/s. Mehul Pitroda (Membership No.43364, CP No. 20308) Practicing Company Secretary is appointed as the Scrutinizer for conducting Postal Ballot only through Remote E-voting process.
Cut Off date fo | 24-Aug-2024 | |
No Dividends has been declared by Remedium_Life
Record Date06-Jul-2024
Ex-Bonus Date05-Jul-2024
Ratio3:1
Record Date29-Jul-2023
Ex-Bonus Date28-Jul-2023
Ratio9:5
Record Date23-Feb-2024
Split Date23-Feb-2024
Face Value (Before/After)5/1
Record Date01-Sep-2023
Split Date01-Sep-2023
Face Value (Before/After)10/5
RightsNo Rights has been declared by Remedium_Life
Book Closure
| 14-Nov-2024 | - | Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Remedium Lifecare Ltd has informed BSE th |
| 31-Oct-2024 | - | In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their |
| 31-Oct-2024 | - | In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their |
| 04-Sep-2024 | 01 Jan'1900 | Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2024 inter alia to consider and approve 1. Acquisition of a company Airowater Glo |
| 24-Aug-2024 | 01 Jan'1900 | M/s. Mehul Pitroda (Membership No.43364, CP No. 20308) Practicing Company Secretary is appointed as the Scrutinizer for conducting Postal Ballot only through Remote E-voting process.
Cut Off date fo |